CLS: Solid results from SUS study - Redeye
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Analys

CLS: Solid results from SUS study - Redeye

{newsItem.title}

Redeye is positive about the results from CLS’s study at Skåne University Hospital. The study shows that LITT was safe and feasible, and that median survival exceeded that of the control group treated with open surgery. These results represent a step forward toward CE marking of the Prism system, which we expect during 2026e.

Länk till analysen i sin helhet: https://www.redeye.se/research/1129930/cls-solid-results-from-sus-study?utm_source=finwire&utm_medium=RSS

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt